{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:34:48Z","timestamp":1759937688884},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5-8","license":[{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Down Syndrome (DS) is caused by trisomy of chromosome 21, which includes the gene for the amyloid precursor protein (APP) and leads to overproduction of beta-amyloid. Clinical-pathological studies indicate that individuals with DS begin demonstrating Alzheimer\u2019s disease (AD) pathology during adolescence and that 100% exhibit such changes by age 40. Individuals with DS therefore represent a highly enriched population for AD. Additionally, owing to their baseline intellectual disability, people with DS represent a more vulnerable group of individuals as compared with other populations. Given the recent developments in AD biomarkers, combined with the prospect of achieving greater efficacy with earlier therapeutic intervention, it is logical to include adults with DS in prevention trials for AD.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Discussion<\/jats:title>\n                        <jats:p>The US Food and Drug Administration has released draft guidance on drug development for early-stage AD, based on the understanding that AD is a progressive disease with symptoms developing decades after the disease process has begun. New biomarkers now permit detection of AD pathology in asymptomatic individuals such that there now exists an opportunity to conduct clinical trials of potentially disease-modifying drugs in the earliest stages of the disease and perhaps have the greatest chance of demonstrating efficacy. As such, clinical trials are being actively planned or conducted in individuals with causative mutations in the APP, presenilin-1 (<jats:italic>PSEN1<\/jats:italic>), and presenilin-2 (<jats:italic>PSEN2<\/jats:italic>) genes.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Summary<\/jats:title>\n                        <jats:p>Individuals with DS comprise perhaps the largest group of people with genetically determined AD, with a worldwide population of about 6 million people. Only by inclusion can we provide access to rational therapies that offer the greatest chance of benefiting this highly at-risk population.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13195-014-0060-7","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T16:04:25Z","timestamp":1410451465000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?"],"prefix":"10.1186","volume":"6","author":[{"given":"Michael S","family":"Rafii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"key":"60_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ: Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade.\n                           Lancet Neurol 2010, 9: 119-128. 10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"60_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC: Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease.\n                           N Engl J Med 2012, 367: 795-804. 10.1056\/NEJMoa1202753","journal-title":"N Engl J Med"},{"key":"60_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","volume":"11","author":"EM Reiman","year":"2012","unstructured":"Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, Fagan AM, Shah AR, Alvarez S, Arbelaez A, Giraldo M, Acosta-Baena N, Sperling RA, Dickerson B, Stern CE, Tirado V, Munoz C, Reiman RA, Huentelman MJ, Alexander GE, Langbaum JB, Kosik KS, Tariot PN, Lopera F: Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin 1 E280A kindred: a case\u2013control study.\n                           Lancet Neurol 2012, 11: 1048-1056. 10.1016\/S1474-4422(12)70228-4","journal-title":"Lancet Neurol"},{"key":"60_CR4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease.\n                           Nat Med 1996, 2: 864-870. 10.1038\/nm0896-864","journal-title":"Nat Med"},{"key":"60_CR5","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/bdra.20735","volume":"88","author":"SE Parker","year":"2010","unstructured":"Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A: Updated national birth prevalence estimates for selected birth defects in the United States, 2004\u20132006.\n                           Birth Defects Res A 2010, 88: 1008-1016. 10.1002\/bdra.20735","journal-title":"Birth Defects Res A"},{"key":"60_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1192\/bjp.180.5.405","volume":"180","author":"N Schupf","year":"2002","unstructured":"Schupf N, Sergievsky GH: Genetic and host factors for dementia in Down\u2019s syndrome.\n                           Br J Psychiatry 2002, 180: 405-410. 10.1192\/bjp.180.5.405","journal-title":"Br J Psychiatry"},{"key":"60_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","volume":"122","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW: Alzheimer\u2019s disease and Down\u2019s syndrome: sharing of a unique cerebrovascular amyloid fibril protein.\n                           Biochem Biophys Res Commun 1984, 122: 1131-1135. 10.1016\/0006-291X(84)91209-9","journal-title":"Biochem Biophys Res Commun"},{"key":"60_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(80)92137-6","volume":"2","author":"CM Yates","year":"1980","unstructured":"Yates CM, Simpson J, Maloney AF, Gordon A, Reid AH: Alzheimer-like cholinergic deficiency in Down syndrome.\n                           Lancet 1980, 2: 979. 10.1016\/S0140-6736(80)92137-6","journal-title":"Lancet"},{"key":"60_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","volume":"3","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.\n                           Neurobiol Dis 1996, 3: 16-32. 10.1006\/nbdi.1996.0003","journal-title":"Neurobiol Dis"},{"key":"60_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0304-3940(01)01657-3","volume":"301","author":"N Schupf","year":"2001","unstructured":"Schupf N, Patel B, Silverman W, Zigman WB, Zhong N, Tycko B, Mehta PD, Mayeux R: Elevated plasma amyloid beta-peptide 1\u201342 and onset of dementia in adults with Down syndrome.\n                           Neurosci Lett 2001, 301: 199-203. 10.1016\/S0304-3940(01)01657-3","journal-title":"Neurosci Lett"},{"key":"60_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jalz.2011.09.229","volume":"8","author":"BL Handen","year":"2012","unstructured":"Handen BL, Cohen AD, Channamalappa U, Bulova P, Cannon SA, Cohen WI, Mathis CA, Price JC, Klunk WE: Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.\n                           Alzheimers Dement 2012, 8: 496-501. 10.1016\/j.jalz.2011.09.229","journal-title":"Alzheimers Dement"},{"key":"60_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archneur.1995.00540280059019","volume":"52","author":"BT Hyman","year":"1995","unstructured":"Hyman BT, West HL, Rebeck GW, Lai F, Mann DM: Neuropathological changes in Down\u2019s syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.\n                           Arch Neurol 1995, 52: 373-378. 10.1001\/archneur.1995.00540280059019","journal-title":"Arch Neurol"},{"key":"60_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.410400518","volume":"40","author":"N Schupf","year":"1996","unstructured":"Schupf N, Kapell D, Lee JH, Zigman W, Canto B, Tycko B, Mayeux R: Onset of dementia is associated with apolipoprotein E epsilon4 in Down\u2019s syndrome.\n                           Ann Neurol 1996, 40: 799-801. 10.1002\/ana.410400518","journal-title":"Ann Neurol"},{"key":"60_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.410430316","volume":"43","author":"VP Prasher","year":"1998","unstructured":"Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC: Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome.\n                           Ann Neurol 1998, 43: 380-383. 10.1002\/ana.410430316","journal-title":"Ann Neurol"},{"key":"60_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","volume":"52","author":"PR Hof","year":"1995","unstructured":"Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH: Age related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome: quantitative regional analysis and comparison with Alzheimer\u2019s disease.\n                           Arch Neurol 1995, 52: 379-391. 10.1001\/archneur.1995.00540280065020","journal-title":"Arch Neurol"},{"key":"60_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1176\/appi.ajp.159.1.74","volume":"159","author":"JS Krasuski","year":"2002","unstructured":"Krasuski JS, Alexander GE, Horwitz B, Rapoport SI, Schapiro MB: Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down\u2019s syndrome: implications for the prodromal phase of Alzheimer\u2019s disease.\n                           Am J Psychiatry 2002, 159: 74-81. 10.1176\/appi.ajp.159.1.74","journal-title":"Am J Psychiatry"},{"key":"60_CR17","first-page":"35","volume-title":"Down Syndrome and Alzheimer\u2019s Disease","author":"JV Haxby","year":"1992","unstructured":"Haxby JV, Schapiro MB: Longitudinal Study of Neuropsychological Function in Older Adults with Down Syndrome. In Down Syndrome and Alzheimer\u2019s Disease. Edited by: Nadel L, Epstein CJ. Wiley-Liss, New York; 1992:35-50."},{"key":"60_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1542\/peds.2009-0745","volume":"124","author":"M Shin","year":"2009","unstructured":"Shin M, Besser LM, Kucik JE, Lu C, Siffel C, Correa A: Prevalence of Down syndrome among children and adolescents in 10 regions of the United States.\n                           Pediatrics 2009, 124: 1565-1571. 10.1542\/peds.2009-0745","journal-title":"Pediatrics"},{"key":"60_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ddrr.1128","volume":"18","author":"WB Zigman","year":"2013","unstructured":"Zigman WB: Atypical aging in Down syndrome.\n                           Dev Disabil Res Rev 2013, 18: 51-67. 10.1002\/ddrr.1128","journal-title":"Dev Disabil Res Rev"},{"key":"60_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","volume":"359","author":"Q Yang","year":"2002","unstructured":"Yang Q, Rasmussen SA, Friedman JM: Mortality associated with Down\u2019s syndrome in the US from 1983 to 1997: a population-based study.\n                           Lancet 2002, 359: 1019-1025. 10.1016\/S0140-6736(02)08092-3","journal-title":"Lancet"},{"key":"60_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00013614-199803000-00007","volume":"13","author":"W Silverman","year":"1998","unstructured":"Silverman W, Zigman WB, Kim H, Krinsky-McHale S, Wisniewski HM: Aging and dementia among adults with mental retardation and Down syndrome.\n                           Topic Geriatr Rehabil 1998, 13: 49-64. 10.1097\/00013614-199803000-00007","journal-title":"Topic Geriatr Rehabil"},{"key":"60_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2788.1995.tb00547.x","volume":"39","author":"VP Prasher","year":"1995","unstructured":"Prasher VP, Filer A: Behavioural disturbance in people with Down\u2019s syndrome and dementia.\n                           J Intellect Disabil Res 1995, 39: 432-436. 10.1111\/j.1365-2788.1995.tb00547.x","journal-title":"J Intellect Disabil Res"},{"key":"60_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1352\/0895-8017(2004)109<126:IAPODI>2.0.CO;2","volume":"109","author":"WB Zigman","year":"2004","unstructured":"Zigman WB, Schupf N, Devenny DA, Miezejeski C, Ryan R, Urv TK, Schubert R, Silverman W: Incidence and prevalence of dementia in elderly adults with mental retardation without Down syndrome.\n                           Am J Ment Retard 2004, 109: 126-141. 10.1352\/0895-8017(2004)109<126:IAPODI>2.0.CO;2","journal-title":"Am J Ment Retard"},{"unstructured":"Guidance for Industry: Alzheimer\u2019s Disease: Developing Drugs for the Treatment of Early Stage Disease. Department of Health and Human Services, Food and Drug Administration, Washington, DC; 2013.","key":"60_CR24"},{"key":"60_CR25","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJMp1302513","volume":"368","author":"N Kozauer","year":"2013","unstructured":"Kozauer N, Katz R: Regulatory innovation and drug development for early-stage Alzheimer\u2019s disease.\n                           N Engl J Med 2013, 368: 1169-1171. 10.1056\/NEJMp1302513","journal-title":"N Engl J Med"},{"key":"60_CR26","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1017\/S0033291798007417","volume":"28","author":"C Oliver","year":"1998","unstructured":"Oliver C, Crayton L, Holland A, Hall S, Bradbury J: A four year prospective study of age-related cognitive change in adults with Down\u2019s syndrome.\n                           Psychol Med 1998, 28: 1365-1377. 10.1017\/S0033291798007417","journal-title":"Psychol Med"},{"key":"60_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1348\/014466599162719","volume":"38","author":"J Hon","year":"1999","unstructured":"Hon J, Huppert FA, Holland AJ, Watson P: Neuropsychological assessment of older adults with Down\u2019s syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG).\n                           Br J Clin Psychol 1999, 38: 155-165. 10.1348\/014466599162719","journal-title":"Br J Clin Psychol"},{"key":"60_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1046\/j.1365-2788.2000.00305.x","volume":"44","author":"DA Devenny","year":"2000","unstructured":"Devenny DA, Krinsky-McHale SJ, Sersen G, Silverman WP: Sequence of cognitive decline in dementia in adults with Down\u2019s syndrome.\n                           J Intellect Disabil Res 2000, 44: 654-665. 10.1046\/j.1365-2788.2000.00305.x","journal-title":"J Intellect Disabil Res"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-014-0060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-014-0060-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-014-0060-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-014-0060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:05:06Z","timestamp":1728921906000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-014-0060-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,12]]},"references-count":28,"journal-issue":{"issue":"5-8","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1186\/s13195-014-0060-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"type":"electronic","value":"1758-9193"}],"subject":[],"published":{"date-parts":[[2014,9,12]]},"assertion":[{"value":"12 September 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}